World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
115
Citations
53204
World Ranking
394
National Ranking
243

Medicine

D-Index
115
Citations
53484
World Ranking
4513
National Ranking
2453

Ralph A. Reisfeld publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ralph A. Reisfeld sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 514 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ralph A. Reisfeld D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ralph A. Reisfeld sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 115 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ralph A. Reisfeld was affiliated with the Scripps Research Institute in the United States. Their scientific career encompassed various aspects of research within the institute's scope.

No specific details about recent papers, frequent co-authors, or publication venues are available for this researcher. Similarly, information regarding book publications, main fields or subfields of study, and main topics of work has not been recorded.

There are no recorded awards or distinctions attributed to Ralph A. Reisfeld. The available data confirms that Reisfeld is deceased.

The lack of detailed records limits a comprehensive overview of their research contributions. However, being affiliated with the Scripps Research Institute situates Reisfeld within a context known for biomedical and life sciences research.

Best Publications

  • Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

    Peter C. Brooks;Anthony M.P. Montgomery;Mauricio Rosenfeld;Ralph A. Reisfeld

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • Tumor Regression by Targeted Gene Delivery to the Neovasculature

    John D. Hood;Mark Bednarski;Ricardo Frausto;Samira Guccione

  • Antibody targeted drugs as cancer therapeutics

    David Schrama;Ralph A. Reisfeld;Jürgen C. Becker

  • Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

    Markus Loeffler;Jörg A. Krüger;Andreas G. Niethammer;Ralph A. Reisfeld

  • Targeting tumor-associated macrophages as a novel strategy against breast cancer

    Yunping Luo;He Zhou;Jörg Krueger;Charles Kaplan

  • Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

    Anthony M. P. Montgomery;Ralph A. Reisfeld;David A. Cheresh

  • Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model.

    Debbie Liao;Yunping Luo;Dorothy Markowitz;Rong Xiang;Rong Xiang

  • Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide.

    M.A. Pellegrino;S. Ferrone;M.P. Dierich;R.A. Reisfeld

  • Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.

    Henry L. Niman;Richard A. Houghten;Leslie E. Walker;Ralph A. Reisfeld

  • Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.

    Barbara M. Mueller;Ralph A. Reisfeld;Thomas S. Edgington;Wolfram Ruf

  • Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

    Gregor Schulz;David A. Cheresh;Nissi M. Varki;Alice Yu

  • A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth.

    Andreas G Niethammer;Rong Xiang;Jürgen C Becker;Harald Wodrich

  • T cell homeostatic proliferation elicits effective antitumor autoimmunity

    Wolfgang Dummer;Andreas G. Niethammer;Roberto Baccala;Brian R. Lawson

  • Electrophoretic Heterogeneity of Polypeptide Chains of Specific Antibodies

    Ralph A. Reisfeld;Parker A. Small

  • Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells

    T F Bumol;R A Reisfeld

  • Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells.

    S D Gillies;E B Reilly;K M Lo;R A Reisfeld

  • Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

    A L Yu;M M Uttenreuther-Fischer;C S Huang;C C Tsui

  • Disialoganglioside GD2 on Human Neuroblastoma Cells: Target Antigen for Monoclonal Antibody-mediated Cytolysis and Suppression of Tumor Growth

    Kalpana Mujoo;David A. Cheresh;Hsin Ming Yang;Ralph A. Reisfeld

  • An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2.

    D A Cheresh;R Pytela;M D Pierschbacher;F G Klier

Frequent Co-Authors

Rong Xiang
Rong Xiang Nankai University
Soldano Ferrone
Soldano Ferrone Harvard University
Stephen D. Gillies
Stephen D. Gillies MSD (United States)
David A. Cheresh
David A. Cheresh University of California, San Diego
Jacquelyn A. Hank
Jacquelyn A. Hank University of Wisconsin–Madison
Jürgen C. Becker
Jürgen C. Becker University of Duisburg-Essen
Barbara M. Mueller
Barbara M. Mueller Torrey Pines Institute For Molecular Studies
Paul M. Sondel
Paul M. Sondel University of Wisconsin–Madison
James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center
Nissi M. Varki
Nissi M. Varki University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals pivot towards roles in nursing and healthcare support, where advanced knowledge of the immune system is invaluable.

Online programs offer great flexibility, especially options like an accelerated nurse practitioner program. These fast-tracked courses enable students to gain advanced clinical skills and certification while balancing other commitments.

If you come from a non-nursing background, consider programs such as online accelerated nursing programs for non nurses. Designed specifically for career changers, they provide a streamlined pathway into nursing professions.

For those looking at foundational nursing roles, researching accelerated nursing programs near me can be a smart first step. These programs often have flexible admission standards to quickly prepare students for the workforce.

Additionally, lpn programs with easiest admission requirements offer accessible entry points into practical nursing roles, which complement immunology expertise in clinical settings.

Best Scientists Citing Ralph A. Reisfeld

Recently Published Articles